About the molecule and how it works.
A specifically engineered anti-VEGF
A single-chain antibody fragment aims to facilitate deeper penetration of active molecules than larger molecules within tissue.1
Beovu has a high affinity to VEGF-A isoforms1 and can inhibit VEGF through prevention of the ligand-receptor interaction.
VEGF, vascular endothelial growth factor; VEGF-A, vascular endothelial growth factor A.
- Gaudreault J et al. Invest Ophthalmol Vis Sci. 2012; 53: 3025.
- Beovu Summary of Product Characteristics, 2020.
- Yannuzzi NA, Freund KB. Clin Ophthalmol. 2019; 13: 1323–1329.